Vall D'hebron Institute Of Oncology
Clinical trials sponsored by Vall D'hebron Institute Of Oncology, explained in plain language.
-
Experimental cell combo for tough breast cancer halted after just 2 patients
Disease control TerminatedThis early-phase study tested whether adding donor natural killer (NK) cells to standard antibody drugs (trastuzumab and pertuzumab) could help people with advanced HER2-positive breast cancer that had stopped responding to other treatments. Only 2 participants were enrolled befo…
Phase: PHASE1 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Cancer drug combo shows promise for Hard-to-Treat bowel cancer
Disease control TerminatedThis study tested a combination of two drugs (atezolizumab and bevacizumab) in 46 people with advanced colorectal cancer that had stopped responding to chemotherapy and had a specific genetic marker called MSI-like. The goal was to see if the combination could shrink tumors. The …
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated May 22, 2026 13:52 UTC